PDF
Summary of National Advisory Committee on Immunization (NACI) Statement of February 2023: Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines
Organization: Public Health Agency of Canada (PHAC)Published: 2023
Summary: The primary objective of this statement is to review the evidence on the efficacy, effectiveness, immunogenicity, safety, and cost-effectiveness of PNEU-C-15 and PNEU-C-20 vaccines and provide recommendations for their use in consideration of the disease burden in Canada among adults for whom pneumococcal vaccination is currently recommended: immunocompetent adults aged 65 and older immunocompetent adults at higher risk of pneumococcal disease (PD), immunocompetent adults residing in long term care facilities (LTCF), immunocompromised adults, including hematopoietic stem cell transplant recipients
Resource Group:
Implementation Tool
Product Type: Guide
Program Delivery and Evaluation
Clinics
Vaccine Preventable Diseases
Communicable Diseases
Pneumococcal Disease
Specific Populations
Adults
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Preventable Diseases,Communicable Diseases,Pneumococcal Disease,Specific Populations,Adults Program Planning and DeliveryProgram Delivery and Evaluation
Clinics
Vaccine Preventable Diseases
Communicable Diseases
Pneumococcal Disease
Specific Populations
Adults
Region:
National
Language:
English
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.